Skip to main content
. 2006 Apr 19;2006(2):CD005321. doi: 10.1002/14651858.CD005321.pub2

26. Clinical benefit table: Hyalgan plus exercise plus ultrasound versus exercise.

Study Time Treatment Outcome N of Pts Baseline Mean End of Study Mean Absolute Benefit Relative Difference
Huang 2005 End of treatment E: Hyalgan+exercise+ultrasound Pain (0‐10 cm VAS) 34 5.6 2.5 ‐1.9 (I) ‐35.8% (I)
    C: Exercise   30 5.3 4.1    
Huang 2005 52 wk E: Hyalgan+exercise+ultrasound Pain (0‐10 cm VAS) 32 5.6 2.0 ‐2.2 (I) ‐41.5% (I)
    C: Exercise   26 5.3 3.9    
Huang 2005 End of treatment E: Hyalgan+exercise+ultrasound Lequesne Index (0‐26) 34 7.5 4.0 ‐5.0 (I) ‐65.8% (I)
    C: Exercise   30 7.6 6.1    
Huang 2005 52 wk E: Hyalgan+exercise+ultrasound Lequesne Index (0‐26) 32 7.5 2.5 ‐3.2 (I) ‐42.1% (I)
    C: Exercise   26 7.6 5.8    
Huang 2005 End of treatment E: Hyalgan+exercise+ultrasound Range of motion (degrees) 34 103 120 22 (I) 21.4% (I)
    C: Exercise   30 103 108    
Huang 2005 52 wk E: Hyalgan+exercise+ultrasound Range of motion (degrees) 32 103 124 28 (I) 27.2% (I)
    C: Exercise   26 103 110    
Huang 2005 End of treatment E: Hyalgan+exercise+ultrasound Ambulation speed (metres per minute) 34 72.4 95.6 12.9 (I) 17.8% (I)
    C: Exercise   30 72.6 82.9    
Huang 2005 52 wk E: Hyalgan+exercise+ultrasound Ambulation speed (metres per minute) 32 72.4 99.3 14.2 (I) 19.6% (I)
    C: Exercise   26 72.6 85.3